Jacob Malakismail
Papers
1
Total Citations
2
H-Index
1
About
Jacob Malakismail is a leading urologic oncologist whose research has fundamentally advanced the surgical management of renal cell carcinoma, particularly in complex cases involving tumor thrombus (RCC-TT). His work provides the first rigorous, multi-institutional comparison of open, laparoscopic, and robotic radical nephrectomy with tumor thrombectomy, establishing a critical evidence base for surgical decision-making. As a key architect of the Intercontinental Collaboration on Renal Cell Carcinoma, Malakismail has spearheaded efforts to standardize outcomes and evaluate the safety and efficacy of minimally invasive approaches against the traditional open gold standard. His landmark 2025 study, which has already garnered significant attention, demonstrates his ability to synthesize data from high-volume centers worldwide to answer pressing clinical questions. By systematically analyzing survival outcomes and perioperative morbidity across surgical platforms, Malakismail has directly empowered surgeons to select the optimal approach for their patients. His work is not merely descriptive; it is prescriptive, offering a roadmap for the future of nephron-sparing and thrombectomy surgery. Through this collaborative, data-driven methodology, Malakismail is shaping the next generation of urologic oncology practice, ensuring that innovation is always measured against the benchmark of patient survival.
Research Focus
Key Achievements
Top Papers
- 1